According to the report, the Size of the Latin America Ureteral Stents Market in Latin America is valued at USD 31.33 Million in 2024 and is poised to reach USD 46.35 Million by 2029, increasing at a CAGR of 8.15% during the forecast period 2024 to 2029.
Ureteral stent refers to a tube which is implanted in ureter to treat blockage of urine flow from kidney. The stent is inserted with the help of a cystoscopy and the length of stent ranges from 24 cm to 30 cm. The ends of stent are coiled to keep them in place.
The significant drivers are increasing incidence of medical conditions which require ureteral stents, growing cases of kidney stones. Increasing geriatric population and increase in government funding is also expected to drive the market over the forecast period. However infections caused due urinary stent and increase in frequency of urination are major restraints limiting this industry.
This research report on the Latin America Ureteral Stents Market has been segmented and sub-segmented into the following categories
By Type:
By Patients Sex:
By End User:
By Medical Situation:
By Country:
On the basis of region, the rising focus of key players on enhancing their market presence across the globe is estimated to encourage the growth of the market in the Latin America regions.
Noteworthy Companies leading the Latin America Ureteral Stents Market Profiled in the Report are UteraC. R. Bard, Inc., Pnn Medical, Cook Medical Inc., Boston Scientific Corporation and Medline Industries, Inc.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region